论文部分内容阅读
目的:分析米索前列醇直肠给药预防产后出血的临床疗效及安全性。方法:选择有产后出血高危因素的阴道分娩产妇120例,随机分为实验组和对照组各60例,其中实验组采用米索前列醇直肠给药预防产后出血。对照组采用缩宫素预防产后出血,观察两组产妇临床疗效及并发症情况。结果:第三产程时间、产后2 h出血量、产后24 h出血量实验组均明显低于对照组,差异有显著的统计学意义(P<0.01)。结论:米索前列醇直肠给药预防产后出血安全有效,值得临床推广应用。
Objective: To analyze the clinical efficacy and safety of misoprostol for rectal bleeding in preventing postpartum hemorrhage. Methods: One hundred and twenty cases of vaginal delivery women who were at risk of postpartum hemorrhage were randomly divided into experimental group and control group with 60 cases each. In the experimental group, misoprostol was administered rectally to prevent postpartum hemorrhage. Oxytocin was used in the control group to prevent postpartum hemorrhage. The clinical efficacy and complications of the two groups were observed. Results: The duration of the third stage of labor, blood loss at 2 h postpartum, and blood loss at 24 h postpartum were significantly lower in the experimental group than in the control group (P <0.01). Conclusion: Misoprostol rectum is safe and effective in preventing postpartum hemorrhage. It is worthy of clinical application.